Urovo Technology Balance Sheet Health
Financial Health criteria checks 5/6
Urovo Technology has a total shareholder equity of CN¥1.5B and total debt of CN¥611.5M, which brings its debt-to-equity ratio to 41%. Its total assets and total liabilities are CN¥2.4B and CN¥936.2M respectively. Urovo Technology's EBIT is CN¥60.8M making its interest coverage ratio -5.2. It has cash and short-term investments of CN¥1.1B.
Key information
41.0%
Debt to equity ratio
CN¥611.53m
Debt
| Interest coverage ratio | -5.2x |
| Cash | CN¥1.14b |
| Equity | CN¥1.49b |
| Total liabilities | CN¥936.22m |
| Total assets | CN¥2.43b |
Recent financial health updates
Recent updates
Is Urovo Technology (SZSE:300531) A Risky Investment?
Sep 27
Optimistic Investors Push Urovo Technology Co., Ltd. (SZSE:300531) Shares Up 45% But Growth Is Lacking
Aug 23Urovo Technology (SZSE:300531) Will Want To Turn Around Its Return Trends
Jul 25Urovo Technology's (SZSE:300531) Dividend Will Be CN¥0.05
May 26Calculating The Intrinsic Value Of Urovo Technology Co., Ltd. (SZSE:300531)
Mar 27Urovo Technology Co., Ltd.'s (SZSE:300531) 27% Price Boost Is Out Of Tune With Earnings
Mar 06Capital Allocation Trends At Urovo Technology (SZSE:300531) Aren't Ideal
Feb 28Financial Position Analysis
Short Term Liabilities: 300531's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥904.0M).
Long Term Liabilities: 300531's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥32.2M).
Debt to Equity History and Analysis
Debt Level: 300531 has more cash than its total debt.
Reducing Debt: 300531's debt to equity ratio has increased from 16.8% to 41% over the past 5 years.
Debt Coverage: 300531's debt is well covered by operating cash flow (29.2%).
Interest Coverage: 300531 earns more interest than it pays, so coverage of interest payments is not a concern.